Surrozen Balance Sheet Health
Financial Health criteria checks 6/6
Surrozen has a total shareholder equity of $30.1M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $36.7M and $6.6M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$27.29m |
| Equity | US$30.14m |
| Total liabilities | US$6.58m |
| Total assets | US$36.72m |
Recent financial health updates
Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?
Jan 03
Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?
Jun 19Here's Why Surrozen (NASDAQ:SRZN) Must Use Its Cash Wisely
Feb 12Recent updates
Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?
Jan 03Will Surrozen (NASDAQ:SRZN) Spend Its Cash Wisely?
Jun 19Here's Why Surrozen (NASDAQ:SRZN) Must Use Its Cash Wisely
Feb 12Surrozen stock rises ~13% premarket on licensing deal with Boehringer Ingelheim
Oct 06Surrozen GAAP EPS of -$0.40 beats by $0.06
Aug 11Surrozen CEO Craig Parker - Biotechs Can Never Be Too Well Capitalized (Video)
Oct 14Financial Position Analysis
Short Term Liabilities: SRZN's short term assets ($32.0M) exceed its short term liabilities ($6.2M).
Long Term Liabilities: SRZN's short term assets ($32.0M) exceed its long term liabilities ($401.0K).
Debt to Equity History and Analysis
Debt Level: SRZN is debt free.
Reducing Debt: SRZN has not had any debt for past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: SRZN has sufficient cash runway for 9 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: SRZN is forecast to have sufficient cash runway for 8 months based on free cash flow estimates, but has since raised additional capital.